Physician profile
Kelly Killeen
NPI 1699807065
$143,591.51
in general payments reported to CMS, 2019-2025
21 companies · $61K in 2025
The $61K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $677 · 2020: $12K · 2021: $20K · 2022: $14K · 2023: $19K · 2024: $17K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $75K · Travel and Lodging: $11K · Food and Beverage: $5,980 · Honoraria: $3,900 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,200 · Gift: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $74,975.21 |
| Travel and Lodging | $11,221.02 |
| Food and Beverage | $5,979.53 |
| Honoraria | $3,900.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,200.00 |
| Gift | $174.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $79,683.34 | 2023-2025 | |
| Allergan, INC. | $40,310.33 | 2019-2022 | |
| Motiva USA, LLC | $9,811.59 | 2024-2025 | |
| Rti Surgical, INC | $5,332.51 | 2023-2025 | |
| Abbott Laboratories | $2,168.42 | 2021 | |
| Kci USA, INC. | $1,600.00 | 2020 | |
| Integra Lifesciences Corporation | $1,500.00 | 2025 | Integra |
| Davol INC. | $1,154.35 | 2022-2025 | Phasix Mesh |
| Sientra, INC. | $500.44 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $463.60 | 2021 | |
| Becton, Dickinson and Company | $456.54 | 2023-2025 | Phasix Mesh |
| Tepha INC | $182.32 | 2019 | |
| Acell, INC. | $124.08 | 2019 | |
| Tela Bio, INC. | $85.92 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Galderma Laboratories, L.P. | $57.22 | 2019-2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $35.90 | 2022-2024 | |
| Vertex Pharmaceuticals Incorporated | $31.44 | 2025 | |
| Solventum Corporation | $29.08 | 2024 | Bair Hugger, 3m Soluprep, Spoton |
| Biocomposites INC | $23.89 | 2025 | Stimulan |
| Merz North America, INC. | $21.01 | 2021 | |
| Hologic Sales and Service, LLC | $19.53 | 2025 | Magseed, Magtrace |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Killeen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.